July 2019

 

In this Issue

Venous Therapy

Addressing the Unknowns

Issue

Supplement

Guest Chief Medical Editors’ Page

Addressing the Unknowns of Venous Care

By Raghu Kolluri, MS, MD, RVT, FSVM; and Manjit Gohel, MD, MBChB, FRCS, FEBVS

COVER STORIES

Surveying the 2019 Venous Stent Landscape

A look at the existing and emerging stents being used to treat venous obstruction.

By Erin H. Murphy, MD, FACS

The Unknowns of Venous Stenting: Why Do Good Cases Go Bad?

An assessment of technical, hematologic, and flow-related factors after stent failure provides a framework for reintervention.

By Stephen A. Black, MD, FRCS(Ed), FEBVS; and Rachael Morris, MD

Panel Discussion: Putting Recent DVT Trial Data Into Context and Practice

Experts discuss the main takeaways of key trials in deep venous thrombosis therapy, nuances in their designs and data, whether the results have affected referrals, and more.

With Riyaz Bashir, MD, FACC, RVT; Rabih Chaer, MD, MSc; Rick de Graaf, MD, PhD; Mitchell J. Silver, DO, FACC, FSVM; and Brooke Spencer, MD, FSIR

C-TRACT Trial: Coming Together to Tackle Chronic DVT

Why C-TRACT is needed, its study design, and how current endovascular practitioners can support it.

By Suresh Vedantham, MD

Panel Discussion: The Case for Robust Screening Programs for Venous Leg Ulcers

A multidisciplinary panel discusses educating providers about early reflux elimination, VLU diagnosis mistakes, identifying appropriate candidates, the potential downsides of large-scale screening programs, and more.

With William Ennis, DO; Manjit Gohel, MD, MBChB, FRCS, FEBVS; Neil Khilnani, MD, FSIR, FACPh; Raghu Kolluri, MS, MD, RVT, FSVM; and Kathleen Ozsvath, MD

Shifting the Focus: Late-Stage Venous Disease

Organizational and research priorities for treating patients with advanced venous disease.

By Safa Salim, BSc, MBBS; Tristan R. A. Lane, BSc, MBBS, PhD, FRCS(Vasc); Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, FFST(Ed); and Sarah Onida, BSc, MBBS, MRCS, PhD

IVC Filter Placement: Is Intersociety Consensus Possible?

An examination of the varying societal guidelines on the use of inferior vena cava filters in treating patients with venous thromboembolism.

By Ariel Borohovitz, MD; and Ido Weinberg, MD

FEATURED TECHNOLOGY

Sponsored by Penumbra, Inc.

Mechanical Power Aspiration With the Indigo® System: Rethinking Clot Removal

With Frank R. Arko III, MD; James F. Benenati, MD; Venita Chandra, MD; Paul Isenbarger, MD; Minhaj S. Khaja, MD, MBA; Maureen P. Kohi, MD, FSIR; and Kumar Madassery, MD
Sponsored by Inari Medical

Treating Common but Complex VTE Scenarios

Drs. Thomas M. Tu, Thomas S. Maldonado, and Suman Annambhotla present case reports using the FlowTriever and ClotTriever Systems for thrombolytic-free, single-session treatments of complex VTE presentations.

With Thomas M. Tu, MD, FACC, FSCAI; Thomas S. Maldonado, MD, FACS; and Suman Annambhotla, MD

EUROPEAN FEATURED TECHNOLOGY

Sponsored by iVascular

Not all DCBs are the same

New-generation coating technologies can influence safety and effectiveness.

By Prof. Ulf Teichgräber, MD, with expert opinion by Koen Deloose, MD

MEDICAL AFFAIRS CORNER

Sponsored by Medtronic

Mixed Ulceration From Arterial and Venous Insufficiency: Is There an Algorithm for Treatment?

By Jon C. George, MD

DEPARTMENTS

An Interview With Alison Halliday, MD

Prof. Halliday discusses the status of enrollment in the ACST-2 trial and its role in the carotid artery stenting trial landscape, guidelines for managing atherosclerotic carotid and vertebral artery disease, and more.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.